Home » Topics » BioWorld Science

BioWorld Science
RSS

Oppilotech awarded grant for bacterial cell wall model

April 27, 2018

AbbVie, Galapagos discover new CFTR modulators

April 27, 2018

Novel STAT5 inhibitors synthesized at Freie Universitaet Berlin

April 27, 2018

Asavi presents inhibitors of HCV NS5B polymerase, HBV DNA polimerase and HIV-1 reverse transcriptase

April 27, 2018

Positive outcome of interim analysis of STRIDE-1 study of AXS-05

April 27, 2018

Achaogen receives funds to support development of aminoglycoside antibiotics

April 27, 2018

Orion Pharma enrolls participants in first-in-human study of ODM-208

April 27, 2018

Duke University patents mitochondrial antiviral-signaling protein compositions

April 27, 2018

Patient recruitment ongoing in phase II/III trial of relatlimab plus nivolumab in melanoma

April 27, 2018

Researchers present gene therapy for methamphetamine-induced inflammation

April 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...